News

Deal Announcements

Fate Therapeutics Adds $9 Million Venture Capital

Thursday, August 23, 2012 5:59:00 AM PDT | VentureDeal
   San Diego, California  --  Biotechnology company Fate Therapeutics has secured $9.2 million in new venture capital financing, according to an SEC regulatory filing.

Fate is developing drugs focused on both regenerative and reprogramming medicine.

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1